Estimating and Examining the Costs of Inpatient Diabetes Care in an Irish Public Hospital

Kathleen Michelle Friel; Patrick Gillepsie; Vivien Coates; Claire-Odile McCauley; Michael McCann; Maurice OKane; Karen McGuigan; Amjed Khamis; Matthew Manktelow

doi:10.1111/dme.14753

Estimating and Examining the Costs of Inpatient Diabetes Care in an Irish Public Hospital

Kathleen Michelle Friel, Patrick Gillepsie, Vivien Coates, Claire-Odile McCauley, Michael McCann, Maurice OKane, Karen McGuigan, Amjed Khamis, Matthew Manktelow

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)

71 Downloads (Pure)

Abstract

AIM: To estimate and examine hospitalisation costs of Type 1 and Type 2 diabetes in an Irish public hospital.

METHODS: A retrospective audit of hospital inpatient admissions over a 5-year period was undertaken, and a wide range of admission-related data were collected for a sample of 7,548 admissions. Hospitalisations were costed using the diagnosis-related group methodology. A series of descriptive, univariate and multivariate regression analyses were undertaken.

RESULTS: The mean hospitalisation cost for Type 1 diabetes was €4,027 and for Type 2 diabetes was €5,026 per admission. Sex, admission type and length of stay were significantly associated with hospitalisation costs for admissions with a primary diagnosis of Type 1 diabetes. Age, admission type, diagnosis status, complications status, discharge destination, length of stay and year were significantly associated with hospitalisation costs for admissions with a primary diagnosis of Type 2 diabetes. Length of stay was associated with higher mean costs, with each additional day increasing Type 1 diabetes costs by €260 (p = 0.001) and Type 2 diabetes by €216 (p < 0.001). Unscheduled admissions were associated with significantly lower costs than elective admissions; €1,578 (p = 0.035) lower for Type 1 diabetes and €2,108 (p < 0.001) lower for Type 2 diabetes.

CONCLUSIONS: This study presents estimates of the costs of diabetes care in the Irish public hospital system and identifies the factors which influence costs for Type 1 and Type 2 diabetes. These findings may be of interest to patients, the public, researchers and those with influence over diabetes policy and practice in Ireland and internationally.

Original language	English
Article number	e14753
Pages (from-to)	1-11
Number of pages	11
Journal	Diabetic medicine
Volume	39
Issue number	4
Early online date	4 Dec 2021
DOIs	https://doi.org/10.1111/dme.14753
Publication status	Published (in print/issue) - 1 Apr 2022

Bibliographical note

Funding Information:
This paper is part of a wider study, the centre for personalised medicine clinical decision‐making and patient safety funded by INTERREG VA and managed by the Special European Union Programmes Body. The views and opinions expressed in this report do not necessarily reflect those of the European Commission or the Special EU programmes Body (SEUPB).

Publisher Copyright:
© 2021 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.

Keywords

Costs
Economic impact
Diabetes Mellitus
Inpatients
Length of stay
Hospitalisation
Internal Medicine
Endocrinology, Diabetes and Metabolism
Endocrinology
costs
inpatients
economic impact
diabetes mellitus
hospitalisation
length of stay

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/dme.14753Licence: CC BY-NC-ND

93313616 - Final Published VersionFinal published version, 168 KBLicence: CC BY-NC-ND

Cite this

@article{9455ef0aff9640d1a707c0534e153d74,

title = "Estimating and Examining the Costs of Inpatient Diabetes Care in an Irish Public Hospital",

abstract = "AIM: To estimate and examine hospitalisation costs of Type 1 and Type 2 diabetes in an Irish public hospital.METHODS: A retrospective audit of hospital inpatient admissions over a 5-year period was undertaken, and a wide range of admission-related data were collected for a sample of 7,548 admissions. Hospitalisations were costed using the diagnosis-related group methodology. A series of descriptive, univariate and multivariate regression analyses were undertaken.RESULTS: The mean hospitalisation cost for Type 1 diabetes was €4,027 and for Type 2 diabetes was €5,026 per admission. Sex, admission type and length of stay were significantly associated with hospitalisation costs for admissions with a primary diagnosis of Type 1 diabetes. Age, admission type, diagnosis status, complications status, discharge destination, length of stay and year were significantly associated with hospitalisation costs for admissions with a primary diagnosis of Type 2 diabetes. Length of stay was associated with higher mean costs, with each additional day increasing Type 1 diabetes costs by €260 (p = 0.001) and Type 2 diabetes by €216 (p < 0.001). Unscheduled admissions were associated with significantly lower costs than elective admissions; €1,578 (p = 0.035) lower for Type 1 diabetes and €2,108 (p < 0.001) lower for Type 2 diabetes.CONCLUSIONS: This study presents estimates of the costs of diabetes care in the Irish public hospital system and identifies the factors which influence costs for Type 1 and Type 2 diabetes. These findings may be of interest to patients, the public, researchers and those with influence over diabetes policy and practice in Ireland and internationally.",

keywords = "Costs, Economic impact, Diabetes Mellitus, Inpatients, Length of stay, Hospitalisation, Internal Medicine, Endocrinology, Diabetes and Metabolism, Endocrinology, costs, inpatients, economic impact, diabetes mellitus, hospitalisation, length of stay",

author = "Friel, {Kathleen Michelle} and Patrick Gillepsie and Vivien Coates and Claire-Odile McCauley and Michael McCann and Maurice OKane and Karen McGuigan and Amjed Khamis and Matthew Manktelow",

note = "Funding Information: This paper is part of a wider study, the centre for personalised medicine clinical decision‐making and patient safety funded by INTERREG VA and managed by the Special European Union Programmes Body. The views and opinions expressed in this report do not necessarily reflect those of the European Commission or the Special EU programmes Body (SEUPB). Publisher Copyright: {\textcopyright} 2021 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. ",

year = "2022",

month = apr,

day = "1",

doi = "10.1111/dme.14753",

language = "English",

volume = "39",

pages = "1--11",

journal = "Diabetic medicine",

issn = "0742-3071",

publisher = "John Wiley & Sons, Inc.",

number = "4",

}

TY - JOUR

T1 - Estimating and Examining the Costs of Inpatient Diabetes Care in an Irish Public Hospital

AU - Friel, Kathleen Michelle

AU - Gillepsie, Patrick

AU - Coates, Vivien

AU - McCauley, Claire-Odile

AU - McCann, Michael

AU - OKane, Maurice

AU - McGuigan, Karen

AU - Khamis, Amjed

AU - Manktelow, Matthew

N1 - Funding Information: This paper is part of a wider study, the centre for personalised medicine clinical decision‐making and patient safety funded by INTERREG VA and managed by the Special European Union Programmes Body. The views and opinions expressed in this report do not necessarily reflect those of the European Commission or the Special EU programmes Body (SEUPB). Publisher Copyright: © 2021 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.

PY - 2022/4/1

Y1 - 2022/4/1

N2 - AIM: To estimate and examine hospitalisation costs of Type 1 and Type 2 diabetes in an Irish public hospital.METHODS: A retrospective audit of hospital inpatient admissions over a 5-year period was undertaken, and a wide range of admission-related data were collected for a sample of 7,548 admissions. Hospitalisations were costed using the diagnosis-related group methodology. A series of descriptive, univariate and multivariate regression analyses were undertaken.RESULTS: The mean hospitalisation cost for Type 1 diabetes was €4,027 and for Type 2 diabetes was €5,026 per admission. Sex, admission type and length of stay were significantly associated with hospitalisation costs for admissions with a primary diagnosis of Type 1 diabetes. Age, admission type, diagnosis status, complications status, discharge destination, length of stay and year were significantly associated with hospitalisation costs for admissions with a primary diagnosis of Type 2 diabetes. Length of stay was associated with higher mean costs, with each additional day increasing Type 1 diabetes costs by €260 (p = 0.001) and Type 2 diabetes by €216 (p < 0.001). Unscheduled admissions were associated with significantly lower costs than elective admissions; €1,578 (p = 0.035) lower for Type 1 diabetes and €2,108 (p < 0.001) lower for Type 2 diabetes.CONCLUSIONS: This study presents estimates of the costs of diabetes care in the Irish public hospital system and identifies the factors which influence costs for Type 1 and Type 2 diabetes. These findings may be of interest to patients, the public, researchers and those with influence over diabetes policy and practice in Ireland and internationally.

AB - AIM: To estimate and examine hospitalisation costs of Type 1 and Type 2 diabetes in an Irish public hospital.METHODS: A retrospective audit of hospital inpatient admissions over a 5-year period was undertaken, and a wide range of admission-related data were collected for a sample of 7,548 admissions. Hospitalisations were costed using the diagnosis-related group methodology. A series of descriptive, univariate and multivariate regression analyses were undertaken.RESULTS: The mean hospitalisation cost for Type 1 diabetes was €4,027 and for Type 2 diabetes was €5,026 per admission. Sex, admission type and length of stay were significantly associated with hospitalisation costs for admissions with a primary diagnosis of Type 1 diabetes. Age, admission type, diagnosis status, complications status, discharge destination, length of stay and year were significantly associated with hospitalisation costs for admissions with a primary diagnosis of Type 2 diabetes. Length of stay was associated with higher mean costs, with each additional day increasing Type 1 diabetes costs by €260 (p = 0.001) and Type 2 diabetes by €216 (p < 0.001). Unscheduled admissions were associated with significantly lower costs than elective admissions; €1,578 (p = 0.035) lower for Type 1 diabetes and €2,108 (p < 0.001) lower for Type 2 diabetes.CONCLUSIONS: This study presents estimates of the costs of diabetes care in the Irish public hospital system and identifies the factors which influence costs for Type 1 and Type 2 diabetes. These findings may be of interest to patients, the public, researchers and those with influence over diabetes policy and practice in Ireland and internationally.

KW - Costs

KW - Economic impact

KW - Diabetes Mellitus

KW - Inpatients

KW - Length of stay

KW - Hospitalisation

KW - Internal Medicine

KW - Endocrinology, Diabetes and Metabolism

KW - Endocrinology

KW - costs

KW - inpatients

KW - economic impact

KW - diabetes mellitus

KW - hospitalisation

KW - length of stay

UR - http://www.scopus.com/inward/record.url?scp=85120466098&partnerID=8YFLogxK

U2 - 10.1111/dme.14753

DO - 10.1111/dme.14753

M3 - Article

C2 - 34839536

SN - 0742-3071

VL - 39

SP - 1

EP - 11

JO - Diabetic medicine

JF - Diabetic medicine

IS - 4

M1 - e14753

ER -

Estimating and Examining the Costs of Inpatient Diabetes Care in an Irish Public Hospital

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this